These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19255983)

  • 1. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
    Neznamov GG; Teleshova ES
    Neurosci Behav Physiol; 2009 Mar; 39(3):311-21. PubMed ID: 19234797
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
    Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamics of cognitive and emotional-volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam].
    Popov IuV; Iakovleva IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):48-52. PubMed ID: 23739514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vinpotropile in the treatment of cerebral vascular diseases].
    Filimonov VA; Kliueva VN; Kondrasheva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
    [No Abstract]   [Full Text] [Related]  

  • 8. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
    Odinak MM; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical features of the formation and possibilities of treatment of posttraumatic cognitive disturbances].
    Litvinenko IV; Emelin AIu; Vorob'ev SV; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):60-6. PubMed ID: 21311490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of cognitive impairment following delayed CO encephalopathy.
    Song IU; Cho HJ; Kim YD; Chung SW
    Can J Neurol Sci; 2011 Nov; 38(6):934-5. PubMed ID: 22030437
    [No Abstract]   [Full Text] [Related]  

  • 13. Correspondence on ''the unrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production''.
    Duane DD
    J Child Neurol; 2009 Dec; 24(12):1578; author reply 1579. PubMed ID: 19955348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of omaron in patients with post-stroke cognitive disorders].
    Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pseudotumorous course of brain demyelinating disease].
    Kislitsyn IuV; Cheremisinov OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):61-3. PubMed ID: 15822744
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
    Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selection of neuromethabolic drug in severe brain injury].
    Zaĭtsev OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):66-9. PubMed ID: 21246892
    [No Abstract]   [Full Text] [Related]  

  • 19. Piracetam improves children's memory after general anaesthesia.
    Fesenko UA
    Anestezjol Intens Ter; 2009; 41(1):16-21. PubMed ID: 19517672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of acatinol memantine in mild cognitive disorder].
    Levin OS; Iunishchenko NA; Dudarova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.